Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study-Reference-Cited by-同舟云学术

Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study

Published:2018-10-17 Issue:22 Volume:124 Page:4383-4392
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Elson Joshua K.¹²,Kachnic Lisa A.³,Kharofa Jordan R.¹²

Affiliation:

1. Department of Radiation Oncology; University of Cincinnati; Cincinnati Ohio

2. Barrett Cancer Center; University of Cincinnati; Cincinnati Ohio

3. Department of Radiation Oncology; Vanderbilt University; Nashville Tennessee

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.31721/fullpdf

Reference21 articles.

1. Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial;Gunderson;Int J Radiat Oncol,2013

2. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08;John;Cancer J Sci Am,1996

3. Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11;Ben-Josef;J Clin Oncol,2010

4. Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans;Menkarios;Radiat Oncol,2007

5. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome;Milano;Int J Radiat Oncol,2005

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of stage I-III squamous cell anal cancer: a comparative effectiveness systematic review;JNCI: Journal of the National Cancer Institute;2024-08-20

2. Brachytherapy for rectal and anal cancer: Where are we and current perspectives?;Brachytherapy;2024-03

3. Acute and Chronic Complications After Treatment of Locoregional Anal Cancer: Prevention and Management Strategies;Journal of the National Comprehensive Cancer Network;2023-11

4. Beyond the heart in hypofractionated radiotherapy and in the transition from 3D to IMRT/VMAT;Reports of Practical Oncology and Radiotherapy;2023-08-28

5. Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE;Radiotherapy and Oncology;2023-06